POLEWACZYK JAMES F
Known title: Executive Vice PresidentCIK: 0001389046
Associated companies
Transaction History
| IDXX | ▲ Buy | Option Exercise | 755 | $156K | 3/6/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 2,226 | $643K | 3/6/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 4,640 | $2.5M | 3/6/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 4,134 | $2.3M | 3/6/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 483 | $100K | 3/6/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,290 | $1.8M | 3/6/2024 | View on chart |
| IDXX | ▼ Sell | Open Market | 680 | $380K | 3/6/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 126 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 216 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 161 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 204 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 220 | $0 | 2/14/2024 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 279 | $156K | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 4,956 | $1.0M | 12/7/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 6,680 | $1.9M | 12/7/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,116 | $1.6M | 12/7/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,378 | $1.8M | 12/7/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 1,202 | $628K | 12/7/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,940 | $2.1M | 12/7/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,887 | $1.5M | 8/29/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 6,186 | $3.2M | 8/29/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 7,473 | $3.8M | 8/29/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 2,627 | $181K | 8/29/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 706 | $100K | 8/29/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 7,151 | $1.0M | 8/29/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 560 | $100K | 8/29/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 5,865 | $1.0M | 8/29/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 500 | $254K | 8/29/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 3,318 | $1.7M | 8/29/2023 | View on chart |
| IDXX | ▼ Sell | Open Market | 2,545 | $1.3M | 8/29/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 126 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 127 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 216 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 161 | $0 | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 204 | $0 | 2/14/2023 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 252 | $127K | 2/14/2023 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 161 | $0 | 2/14/2022 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 235 | $119K | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 150 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 126 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 127 | $0 | 2/14/2022 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 217 | $0 | 2/14/2022 | View on chart |
| IDXX | ▼ Sell | Open Market | 4,595 | $2.9M | 11/29/2021 | View on chart |
| IDXX | ▼ Sell | Gift | 522 | $0 | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating
KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.